Nasal Congestion Global Clinical Trials Review, H1, 2013

GlobalData
March 31, 2013
79 Pages - SKU: GBDT5014098
Countries covered: Global



Nasal Congestion Global Clinical Trials Review, H1, 2013

Summary

GlobalData's clinical trial report, “Nasal Congestion Global Clinical Trials Review, H1, 2013 provides data on the Nasal Congestion clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nasal Congestion. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nasal Congestion. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies


Additional Information


Report Excerpt

Introduction

Constipation

Report Guidance

Constipation Global Clinical Trials Review, H1, 2013 outlines clinical trials in constipation. The prominent features of this report are-

1. Comprehensive data related to the constipation clinical trials by region, country, and phase, recruitment status.
2. Clinical trials conducted by key companies and institutes / universities / hospitals. The selection of the sponsors is based on their total number of constipation clinical trials conducted by them.
3. A list of key drugs under development or present in the market is provided. The selection of this list is the market size of the products, the number of clinical trials in which they were investigated.
4. The clinical trials compiled in this report are from 70 registries across the globe, taken from 1982 to as of March 2013

More Respiratory/Pulmonary reports by GlobalData

Wheezing Global Clinical Trials Review, H2, 2014 by GlobalData
Wheezing Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Wheezing Global Clinical Trials Review, H2, 2014 provides data on the Wheezing clinical trial scenario. ...
Tracheobronchitis Global Clinical Trials Review, H2, 2014 by GlobalData
Tracheobronchitis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Tracheobronchitis Global Clinical Trials Review, H2, 2014 provides data on the Tracheobronchitis clinical trial scenario. ...
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014 by GlobalData
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical ...
Respiratory Depression Global Clinical Trials Review, H2, 2014 by GlobalData
Respiratory Depression Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Respiratory Depression Global Clinical Trials Review, H2, 2014 provides data on the Respiratory Depression ...
See all reports like this >>

More Global Respiratory/Pulmonary reports

Respiratory Syncytial Virus (RSV) Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 by DelveInsight
Respiratory Syncytial Virus (RSV) Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015DelveInsight’s, “Respiratory Syncytial Virus (RSV) Infections-Global API Manufacturers, Marketed and Phase III ...
Respiratory Hypersensitivity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 by DelveInsight
Respiratory Hypersensitivity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015DelveInsight’s, “Respiratory Hypersensitivity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive ...
Respiratory Distress Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 by DelveInsight
Respiratory Distress Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015DelveInsight’s, “Respiratory Distress Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report ...
Pulmonary Tuberculosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 by DelveInsight
Pulmonary Tuberculosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015DelveInsight’s, “Pulmonary Tuberculosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 2,500  
    Site License  USD 5,000  
    Global Site License  USD 7,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!